Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > tourniquet

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Feb 15, 2023 11:54am

278 Views

Post# 35287541

tourniquet

Groome et al did a nice job of applying the touriquet yesterday.

Shareholders less concerned and now see Q1 (H1?) as more of an anomaly versus the new norm, or an indicator of serious issues.

I feel a bit more reassured, but still see this a "show me" stock...which, if that happens in Q2 or Q3 should get us back into the .50's at least.

MM

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market